New Mexico Educational Retirement Board reduced its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 8.1% during the second quarter, according to its most recent filing with the SEC. The firm owned 3,388 shares of the medical equipment provider’s stock after selling 300 shares during the period. New Mexico Educational Retirement Board’s holdings in Intuitive Surgical were worth $3,179,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors also recently bought and sold shares of the company. Macquarie Group Ltd. raised its stake in shares of Intuitive Surgical by 11.7% in the fourth quarter. Macquarie Group Ltd. now owns 19,900 shares of the medical equipment provider’s stock valued at $12,620,000 after buying an additional 2,090 shares in the last quarter. Gulf International Bank UK Ltd raised its stake in shares of Intuitive Surgical by 2.1% in the first quarter. Gulf International Bank UK Ltd now owns 12,065 shares of the medical equipment provider’s stock valued at $9,247,000 after buying an additional 250 shares in the last quarter. National Pension Service raised its stake in shares of Intuitive Surgical by 2.9% in the first quarter. National Pension Service now owns 29,512 shares of the medical equipment provider’s stock valued at $22,614,000 after buying an additional 837 shares in the last quarter. Ipswich Investment Management Co. Inc. raised its stake in shares of Intuitive Surgical by 13.0% in the first quarter. Ipswich Investment Management Co. Inc. now owns 390 shares of the medical equipment provider’s stock valued at $299,000 after buying an additional 45 shares in the last quarter. Finally, Howard Capital Management purchased a new stake in shares of Intuitive Surgical during the first quarter valued at about $230,000. Institutional investors own 96.08% of the company’s stock.
Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) traded up 1.15% during mid-day trading on Friday, reaching $984.31. The company had a trading volume of 385,160 shares. The firm has a 50-day moving average price of $946.69 and a 200-day moving average price of $844.19. Intuitive Surgical, Inc. has a 1-year low of $610.71 and a 1-year high of $993.00. The stock has a market capitalization of $36.57 billion, a price-to-earnings ratio of 47.15 and a beta of 0.39. Intuitive Surgical shares are set to split on Thursday, August 31st. The 3-1 split was announced on Friday, August 11th. The newly issued shares will be payable to shareholders after the closing bell on Wednesday, August 30th.
Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Thursday, July 20th. The medical equipment provider reported $5.95 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $5.79 by $0.16. The firm had revenue of $756.20 million during the quarter, compared to analyst estimates of $724.51 million. Intuitive Surgical had a return on equity of 15.99% and a net margin of 28.44%. The business’s revenue for the quarter was up 12.8% compared to the same quarter last year. During the same period in the previous year, the company posted $5.62 EPS. Equities analysts expect that Intuitive Surgical, Inc. will post $23.92 earnings per share for the current year.
Several analysts have issued reports on ISRG shares. Citigroup Inc. reaffirmed a “buy” rating and issued a $917.00 target price (up previously from $820.00) on shares of Intuitive Surgical in a research note on Saturday, April 22nd. Zacks Investment Research raised Intuitive Surgical from a “hold” rating to a “buy” rating and set a $1,024.00 target price for the company in a research note on Wednesday, May 31st. Jefferies Group LLC reaffirmed a “buy” rating and issued a $675.00 target price on shares of Intuitive Surgical in a research note on Tuesday, April 25th. Goldman Sachs Group, Inc. (The) started coverage on Intuitive Surgical in a research note on Tuesday, May 16th. They issued a “buy” rating and a $1,000.00 target price for the company. Finally, Bank of America Corporation reaffirmed a “buy” rating and issued a $1,000.00 target price on shares of Intuitive Surgical in a research note on Thursday, June 1st. Five analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has given a strong buy rating to the stock. The company presently has an average rating of “Buy” and a consensus target price of $980.61.
In other news, CEO Gary S. Guthart sold 17,975 shares of the business’s stock in a transaction on Thursday, July 27th. The stock was sold at an average price of $937.27, for a total value of $16,847,428.25. Following the completion of the transaction, the chief executive officer now directly owns 101,798 shares of the company’s stock, valued at approximately $95,412,211.46. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Amal M. Johnson sold 1,000 shares of the company’s stock in a transaction dated Wednesday, May 31st. The shares were sold at an average price of $917.27, for a total value of $917,270.00. Following the transaction, the director now directly owns 3,787 shares in the company, valued at $3,473,701.49. The disclosure for this sale can be found here. Over the last three months, insiders sold 34,065 shares of company stock valued at $31,659,090. Corporate insiders own 2.50% of the company’s stock.
About Intuitive Surgical
Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Receive News & Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.